New test for severe corneal infection diagnosis
Part of Eyes & vision, Infections clinical trials.
This study tests a new method for identifying bacteria causing severe corneal infections. It may help doctors choose the right treatment faster by improving how the infection is identified from corneal samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be admitted to the hospital for severe corneal infection (infectious keratitis)
- Have French social security/health coverage
- Be willing and able to take part in the study
- Be able to understand the study and give consent (or consent is possible)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new, non-invasive (no needles or surgery) way to diagnose a type of eye infection called microbial keratitis. It may help find the cause faster so you get the right treatment sooner.
This study looks at all patients with microbial keratitis (a serious eye infection) to understand the patterns of these infections. It may help improve treatment for eye infections in the future.
This study looks at how doctors collect and test eye infection samples to get more accurate results, especially in serious cases like corneal abscess or deep eye infection. If you have signs of a complex eye infection and a sample is needed, this trial may help improve the way diagnosis is done for patients like you.
This trial looks at lab test results from samples taken to check for a serious (invasive) fungal infection caused by fusarium. It may help improve how doctors identify the infection and its drug resistance, which can guide better treatment.
This study looks for genetic reasons why some people get very serious infections. If you or a family member has had a rare, severe infection, researchers will analyze your DNA to find genes that might make you more vulnerable.
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
Hear when a new Infectious Keratitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.